<DOC>
	<DOCNO>NCT01992601</DOCNO>
	<brief_summary>This clinical trial design compare pharmacokinetic characteristic combination separate administration Crestor ( Rosuvastatin ) Micardis ( Telmisartan ) . Also investigate drug interaction separate combination administration . Total number subject 48 . 4 group ( 12 1 group ) , 2 period , consecutive 6 day administration , 16 day washout 6th day administration . The subject Part 1 take Crestor alone Crestor+Micardis combination cross-over design 2 period . The subject Part 2 take Micardis alone Crestor+Micardis combination cross-over design 2 period .</brief_summary>
	<brief_title>A Randomized , Open-label , Multiple-dose , Crossover Study Investigate Pharmacokinetic Drug Interaction Between Rosuvastatin Telmisartan Healthy Volunteer</brief_title>
	<detailed_description />
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>1 . Healthy male female age 20 50 body mass index ( BMI ) 19 27 kg/m2 2 . Acceptable medical history , physical examination , laboratory test EKG , screen 3 . Provision sign write informed consent •20~50 yr old , healthy Korean Subjects 1.History clinically significant disease 2.Sitting blood pressure meeting follow criterion screen : 150 ≤ systolic blood pressure ≤90 ( mmHg ) 95 ≤ diastolic blood pressure ≤ 50 ( mmHg ) amd 100 ≤ Heart rate ≤ 40 3 . A history drug abuse presence positive reaction drug abuse potential urine screening drug . 4 . Administration investigational product within 90 day prior first dosing . 5 . Administration herbal medicine within 30 day administration ethical drug within 14 day administration overthecounter ( OTC ) drug within 7 day prior first dose investigational product ( investigator ( study doctor ) determine person meet criteria appropriately , relevant person may participate study ) . 6.Have AST ( SGOT ) or/and ALT ( SGPT ) &gt; 3 time normal upper limit time screen 7 . Volunteers consider eligible clinical trial investigator ( study doctor ) due reason include laboratory test result , ECGs , vital sign .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Drug interaction</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Telmisartan</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>( Pharmacokinetics Drug Interaction )</keyword>
</DOC>